| Family | Gene | UniprotID | PDB | Resolution | Activity | Spatial-Dihedral | Chelix-SaltBridge | ActLoopNT-ActLoopCT | APEtype | APEdihe | APEdist | Ligand | Ligand Type | Residues in structure | Unresolved residues in A-loop | Phosphorylation | Mutation | Protein |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TYR | INSR | INSR_HUMAN | 2B4SB | 2.3 | Inactive | DFGin‑ABAminus | in-in | in-in | TYR | APEdihe_iiiai | APEdist_aaai | No_ligand | No_ligand | 1014 - 1310 | 0 | PTR1185,PTR1189,PTR1190 | C1008S | Insulin receptor |
| TYR | INSR | INSR_HUMAN | 2B4SD | 2.3 | Inactive | DFGin‑ABAminus | in-in | in-in | TYR | APEdihe_iiiai | APEdist_aaai | No_ligand | No_ligand | 1014 - 1310 | 0 | PTR1185,PTR1189,PTR1190 | C1008S | Insulin receptor |
| Family | Gene | UniprotID | PDB | Resolution | Activity | Spatial-Dihedral | Chelix-SaltBridge | ActLoopNT-ActLoopCT | APEtype | APEdihe | APEdist | Ligand | Ligand Type | Residues in structure | Unresolved residues in A-loop | Phosphorylation | Mutation | Protein | Organism |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TYR | INSR | INSR_HUMAN | 2B4SB | 2.3 | Inactive | DFGin‑ABAminus | in-in | in-in | TYR | APEdihe_iiiai | APEdist_aaai | No_ligand | No_ligand | 1014 - 1310 | 0 | PTR1185,PTR1189,PTR1190 | C1008S | Insulin receptor | Homo sapiens |
| TYR | INSR | INSR_HUMAN | 2B4SD | 2.3 | Inactive | DFGin‑ABAminus | in-in | in-in | TYR | APEdihe_iiiai | APEdist_aaai | No_ligand | No_ligand | 1014 - 1310 | 0 | PTR1185,PTR1189,PTR1190 | C1008S | Insulin receptor | Homo sapiens |
| Spatial label | Dihedral label | Number of Chains | Percent | Representative |
|---|
| Family | Gene | UniprotID | PDB | Resolution | Activity | Spatial-Dihedral | Chelix-SaltBridge | ActLoopNT-ActLoopCT | APEtype | APEdihe | APEdist | Ligand | Ligand Type | Residues in structure | Unresolved residues in A-loop | Phosphorylation | Mutation | Protein | Organism |
|---|